IP Library Patent Application 18737713
Patent Application
App. No. 18/737,713

ALBUMIN BINDING DOMAIN FUSION PROTEINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/737,713
Abstract

Compositions that include an albumin binding domain and a fusion partner (e.g., a cytokine or a binding moiety) are provided. Such therapeutics have increased serum half-life and find use in applications where one or more such therapeutics are needed, for example, in oncology applications.

Claims (5)

1 . An IL-12/IL-15 albumin binding domain fusion protein comprising the amino acid sequence of SEQ ID NO: 225.

2 . A nucleic acid encoding the 12/IL-15 albumin binding domain fusion protein of claim 2 .

3 . An expression vector comprising the nucleic acid of claim 3 .

4 . A host cell comprising the nucleic acid of claim 2 or the expression vector of claim 3 .

5 . A method of making an 12/IL-15 albumin binding domain fusion protein comprising culturing the host cell of claim 4 under conditions wherein the 12/IL-15 albumin binding domain fusion protein is expressed, and recovering the 12/IL-15 albumin binding domain fusion protein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2026
From: SONNET BIOTHERAPEUTICS, INC.
To: GUIDANT BIOTHERAPEUTICS, INC.
Reel/Frame 074543/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2024
From: CINI, JOHN K.; HUANG, HAOMIN
To: SONNET BIOTHERAPEUTICS, INC.
Reel/Frame 068449/0812 →